Recruiting NCT04340817
Fatty Liver Disease in Nordic Countries
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Proteomics, Transcriptomics, Genomics.
- Who it may be relevant to
- Registry conditions: Non-Alcoholic Fatty Liver Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Denmark
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Fatty Liver Disease in Nordic Countries (FLINC): a Prospective Cohort Study
Overview
A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.
Interventions
- Diagnostic test Proteomics
Mass-spectometry proteomics - Diagnostic test Transcriptomics
Next generation sequencing - Genetic Genomics
Targeted genetics
Primary outcome measures
- Fibrosis [Time frame: 5 years]
Eligibility criteria
Inclusion criteria
- Non-alcoholic fatty liver disease and
- Healthy volunteers
Exclusion criteria
- Other liver diseases than non-alcoholic fatty liver disease
- Lack of informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Denmark · 1 center
- Gastrounit, Copenhagen University Hospital Hvidovre — Hvidovre
Identifiers
NCT: NCT04340817 · Flinc07042020